CI&T (NYSE:CINT – Get Free Report) and OneMedNet (NASDAQ:ONMD – Get Free Report) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, dividends, institutional ownership, valuation, analyst recommendations, profitability and earnings.
Volatility and Risk
CI&T has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, OneMedNet has a beta of 1.1, suggesting that its stock price is 10% more volatile than the S&P 500.
Profitability
This table compares CI&T and OneMedNet’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CI&T | 7.83% | 12.42% | 6.74% |
| OneMedNet | -411.11% | N/A | -262.52% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CI&T | $439.11 million | 1.44 | $29.49 million | $0.27 | 17.37 |
| OneMedNet | $494,000.00 | 135.26 | -$10.13 million | ($0.05) | -26.20 |
CI&T has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than CI&T, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
92.5% of CI&T shares are held by institutional investors. Comparatively, 0.9% of OneMedNet shares are held by institutional investors. 46.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Analyst Recommendations
This is a summary of recent recommendations and price targets for CI&T and OneMedNet, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CI&T | 0 | 3 | 4 | 1 | 2.75 |
| OneMedNet | 1 | 0 | 0 | 0 | 1.00 |
CI&T currently has a consensus target price of $7.16, suggesting a potential upside of 52.67%. Given CI&T’s stronger consensus rating and higher possible upside, equities analysts plainly believe CI&T is more favorable than OneMedNet.
Summary
CI&T beats OneMedNet on 13 of the 15 factors compared between the two stocks.
About CI&T
CI&T, Inc. provides strategy, design and software engineering services to enable digital transformation. The firm’s solutions and services include Digital Strategy, Customer-Centric Design and Top-of-the-Line Software Engineering. The company was founded by Cesar Nivaldo Gon, Bruno Guiçardi Neto and Fernando Matt Borges Martins on June 7, 2021 and is headquartered in Sao Paulo, Brazil.
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Receive News & Ratings for CI&T Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CI&T and related companies with MarketBeat.com's FREE daily email newsletter.
